Alnylam Pharmaceuticals and The Medicines Company Announce that New ALN-PCSsc Results from Late-Breaking Presentation at American Heart Association Meeting Confirm Potential for Bi-Annual Hypercholest

Go back to Alnylam Pharmaceuticals and The Medicines Company Announce that New ALN-PCSsc Results from Late-Breaking Presentation at American Heart Association Meeting Confirm Potential for Bi-Annual Hypercholest
Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) Delayed: 239.56 -5.95 (2.42%)
Previous Close $245.51    52 Week High $109.10 
Open $246.41    52 Week Low $31.38 
Day High $246.49    P/E N/A 
Day Low $238.51    EPS $-1.45 
Volume 2,756,179       

Kirin Holdings Company, Limited Sponsored ADR (AMEX: KNBWY) Delayed: 18.14 -0.47 (2.53%)
Previous Close $18.61    52 Week High $18.64 
Open $18.14    52 Week Low $12.59 
Day High $18.22    P/E N/A 
Day Low $17.35    EPS $0.00 
Volume 31,479       

Medicines Co (NASDAQ: MDCO) Delayed: 84.90 --0 (-0%)
Previous Close $84.90    52 Week High $43.00 
Open $3.15    52 Week Low $27.50 
Day High $84.90    P/E 339.60 
Day Low $84.90    EPS $0.25 
Volume 413,822